Inflammation may limit muscle-building benefits of high-protein nutrition during treatment
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Inflammation may limit muscle-building benefits of high-protein nutrition during treatment
A post-hoc analysis of the PRIMe trial found that baseline systemic inflammation influenced the effectiveness of high-protein nutritional support to increase lean soft tissue in patients with stage II-IV colorectal cancer.